Source: Health Canada shortage reports · Updated Jul 9, 2026
Tetradecyl has no current shortage reported in Canada. It has been in shortage before; the history is below.
A sclerosing agent injected to treat varicose and spider veins.
Products affected
0 / 2
Reports on file
12
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Resolved
TROMBOJECT 3%
30MG · SOLUTION · OMEGA LABORATORIES LIMITED
DIN 00511226 · ended Nov 12, 2025 · Disruption of the manufacture of the drug.
Resolved
TROMBOJECT 1%
10MG · SOLUTION · OMEGA LABORATORIES LIMITED
DIN 00511234 · ended Apr 7, 2024 · Disruption of the manufacture of the drug.
Resolved
TROMBOJECT 3%
30MG · SOLUTION · OMEGA LABORATORIES LIMITED
DIN 00511226 · ended Feb 7, 2024 · Disruption of the manufacture of the drug.
Resolved
TROMBOJECT 1%
10MG · SOLUTION · OMEGA LABORATORIES LIMITED
DIN 00511234 · ended Oct 27, 2023 · Disruption of the manufacture of the drug.
Resolved
TROMBOJECT 3% INJ 30MG/ML
30MG · SOLUTION · OMEGA LABORATORIES LTD
DIN 00511226 · ended Jan 8, 2021 · Manufacturing delay
Resolved
TROMBOJECT 3% INJ 30MG/ML
30MG · SOLUTION · OMEGA LABORATORIES LTD
DIN 00511226 · ended Jan 8, 2021 · Manufacturing delay
Resolved
TROMBOJECT 1% INJ 10MG/ML
10MG · SOLUTION · OMEGA LABORATORIES LTD
DIN 00511234 · ended Feb 4, 2019 · Disruption of the manufacture of the drug.
Resolved
TROMBOJECT 3% INJ 30MG/ML
30MG · SOLUTION · OMEGA LABORATORIES LTD
DIN 00511226 · ended Feb 4, 2019 · Disruption of the manufacture of the drug.
Resolved
TROMBOJECT 3% INJ 30MG/ML
30MG · SOLUTION · OMEGA LABORATORIES LTD
DIN 00511226 · ended Feb 4, 2019 · Disruption of the manufacture of the drug.
Resolved
TROMBOJECT 3% INJ 30MG/ML
30MG · SOLUTION · OMEGA LABORATORIES LTD
DIN 00511226 · ended Jun 11, 2018 · Product now available.
Resolved
TROMBOJECT 3% INJ 30MG/ML
30MG · SOLUTION · OMEGA LABORATORIES LTD
DIN 00511226 · ended Jun 11, 2018 · Product now available.
Resolved
TROMBOJECT 1% INJ 10MG/ML
10MG · SOLUTION · OMEGA LABORATORIES LTD
DIN 00511234 · ended Jun 11, 2018 · Product now available.
What's happening
There are no active shortage reports for Tetradecyl. Health Canada has 12 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.
Tetradecyl is classified under “ANTIVARICOSE THERAPY” (ATC C05BB).
Recent changes
No changes recorded yet.
Common questions
What is Tetradecyl used for?
A sclerosing agent injected to treat varicose and spider veins.
When will Tetradecyl be back in stock in Canada?
Tetradecyl has no active shortage; supply is normal per Health Canada reports.
Why is Tetradecyl in shortage?
It isn't currently. Past reports and their reasons are listed above.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.